Clinical trials
Recruiting Phase 2 Neoplasms by Site trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cogent Biosciences, Inc. | 1 |
| Corcept Therapeutics | 1 |
| Genelux Corporation | 1 |
| Jiangxi Provincial Cancer Hospital | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Orca Biosystems, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 6 |
| Neoplasms | 5 |
| Neoplasms by Histologic Type | 3 |
| Hematologic Diseases | 2 |
| Hematologic Neoplasms | 2 |
| Immune System Diseases | 2 |
| Leukemia | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Acute Disease | 1 |
| Bone Marrow Diseases | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.